Second Degree Burn Clinical Trial
Official title:
An Open, Parallel, Randomized, Comparative, Multi-centre Investigation in US Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene® in the Treatment of Partial Thickness Burns.
The primary objective is to compare the incremental costs (direct and indirect) and benefits
(healing outcomes, quality of life) of using foam silver dressing (Mepilex® Ag) to a Silver
sulfadiazine 1% cream (Silvadene®) from the perspective of the health care provider.
The secondary objectives are to investigate the safety, the tolerance and the performance on
burn status including pain.
In- and/or out-patients at ten centers in the United States were included in this investigation. Subjects included were 5 years of age and older who suffered from partial thickness burns. Every patient was followed for 3 weeks. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01055587 -
Diagnostic of Infections Following Major Abdominal Surgery and Burn Injury
|
N/A | |
Withdrawn |
NCT04684121 -
Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing
|
Phase 2 |